Clinical Study of Recombinant Humanized CTLA-4-FC Fusion Protein Injection in Healthy Subjects
Clinical trial NCT05256719 · UNKNOWN
Trial details
- NCT number
- NCT05256719
- Sponsor
- Beijing VDJBio Co., LTD.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-21
- Primary completion
- 2025-12-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.